T-2 Mycotoxin
- Overview
- Theory
- Diagnosis
- Management
- Follow up
- Resources
Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
all patients
observation
Early signs of T-2 poisoning will reflect the route of exposure. However, as any route of exposure may lead to systemic symptoms, all patients require observation and monitoring for progression of toxicity over 24 to 48 hours.
supportive care
Treatment recommended for ALL patients in selected patient group
Supportive care is the mainstay of management.
Suspected or confirmed cases of T-2 mycotoxin poisoning should be assessed and monitored for adequacy of airway-protective reflexes (gag and cough), adequacy of oxygenation, and adequacy of ventilation.
Airway control and mechanical ventilation should be considered for any patient with upper airway compromise or a decline in ventilation.
There are no available effective antidotes.
intravenous fluid replacement therapy
Additional treatment recommended for SOME patients in selected patient group
In patients with profuse or intractable vomiting and diarrhoea, aggressive fluid and electrolyte replacement is indicated.
activated charcoal
Additional treatment recommended for SOME patients in selected patient group
Gastrointestinal decontamination with activated charcoal may reduce the absorption of toxins from the stomach and could reduce the severity of poisoning if used soon after ingestion.
Primary options
activated charcoal: consult specialist for guidance on dose
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer